TRACLEER Side Effects

7008704-1 | Anaemia, Pancytopenia
on Sep 10, 2010 Female patient from JAPAN , 85 years of age, weighting 72.75 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pancytopenia. Tracleer dosage: 62.5 Mg, Qd, Oral. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), IMIDAPRIL HYDROCHLORIDE (IMIDAPRIL HYDROCHLORIDE) (View Imidapril Hydrochloride (imidapril Hydrochloride) Review and Imidapril Hydrochloride (imidapril Hydrochloride) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ECABET MONOSODIUM (View Ecabet Monosodium Review and Ecabet Monosodium Label ).

6986107-3 | Thrombocytopenia
Patient was taking Tracleer (View Usage). Patient had the following side effects: thrombocytopenia on Sep 03, 2010 from JAPAN Additional patient health information: Female patient , 75 years of age, weighting 90.39 lb, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: See Image. During the same period patient was treated with BERAPROST SODIUM (View Beraprost Sodium Review and Beraprost Sodium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SARPOGRELATE HYDROCHLORIDE (View Sarpogrelate Hydrochloride Review and Sarpogrelate Hydrochloride Label ). Patient was hospitalized.

6986106-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder, Viral Infection
Adverse event was reported on Sep 03, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: 93..75 Mg, Bid, Oral 15.63 Mg, Bid, Oral 31.25 Mg Bid Oral, 62.5 Mg Bid, Oral) was diagnosed with pulmonary arterial hypertension and. Location: JAPAN , 19 years of age, weighting 99.21 lb, After Tracleer was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, viral infection (What is viral infection?). During the same period patient was treated with MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), PYRIDOXAL PHOSPHATE (View Pyridoxal Phosphate Review and Pyridoxal Phosphate Label ), FLAVINE ADENINE DINUCLEOTIDE (View Flavine Adenine Dinucleotide Review and Flavine Adenine Dinucleotide Label ). Patient was hospitalized.

6986105-X | Anuria, Cardiogenic Shock, Cytolytic Hepatitis, International Normalised Ratio Increased, Off Label Use, Resuscitation, Right Ventricular Failure, Ventricular Tachycardia
on Sep 01, 2010 Male patient from FRANCE , 78 years of age, weighting 176.4 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, cardiogenic shock, cytolytic hepatitis, international normalised ratio increased, off label use, resuscitation, right ventricular failure, ventricular tachycardia. Tracleer dosage: 125 Mg, Bid, Oral 62.5 Mg, Bid Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.


6986045-6 | Device Related Infection
on Sep 01, 2010 Female patient from UNITED STATES , 53 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: device related infection. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), PARENTERAL (CALCIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM A (View Parenteral (calcium Chloride Hexahydrate, Potassium Chloride, Sodium A Review and Parenteral (calcium Chloride Hexahydrate, Potassium Chloride, Sodium A Label ). Patient was hospitalized.

6986043-2 | Liver Disorder, Liver Function Test Abnormal
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: liver disorder, liver function test abnormal on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 125 Mg, Bid , Oral. During the same period patient was treated with REMODULIN (View Remodulin Review and Remodulin Label ), REVATIO (View Revatio Review and Revatio Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6986039-0 | Colon Cancer, Renal Cancer
Adverse event was reported on Aug 30, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: Unk Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: colon cancer, renal cancer. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6986038-9 | Bronchitis, Chronic Obstructive Pulmonary Disease, Emphysema
on Sep 02, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, emphysema. Tracleer dosage: Unk Oral. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6986037-7 | Hepatic Function Abnormal, Renal Impairment
on Aug 30, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: hepatic function abnormal, renal impairment. Tracleer dosage: Unk Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6986036-5 | Right Ventricular Failure, Urinary Tract Infection
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: right ventricular failure, urinary tract infection (What is urinary tract infection?) on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Unk Mg Unk Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6986035-3 | Tricuspid Valve Incompetence
Adverse event was reported on Sep 02, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Unk Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 89 years of age, Patient had the following side effects: tricuspid valve incompetence.

6986032-8 | Gastric Disorder
on Aug 31, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: gastric disorder. Tracleer dosage: Unk Oral. During the same period patient was treated with REVATIO(SILDENAFIL ACETATE) (View Revatio(sildenafil Acetate) Review and Revatio(sildenafil Acetate) Label ). Patient was hospitalized.

6986028-6 | Abasia, Anaemia, Asthenia, Cardiac Pacemaker Insertion, Chest X-ray Abnormal, Collagen-vascular Disease, Condition Aggravated, Gait Disturbance, Left Ventricular Failure
on Aug 30, 2010 Female patient from UNITED STATES , 63 years of age, weighting 278.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, anaemia, asthenia, cardiac pacemaker insertion, chest x-ray abnormal, collagen-vascular disease, condition aggravated, gait disturbance, left ventricular failure. Tracleer dosage: 125 Mg Bid Oral. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM ACETATE (CALCIUM ACETATE) (View Calcium Acetate (calcium Acetate) Review and Calcium Acetate (calcium Acetate) Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ). Patient was hospitalized.

6986027-4 | Dyspnoea, Impaired Healing, Leg Amputation, Off Label Use, Peripheral Vascular Disorder, Skin Graft, Skin Ulcer, Toe Amputation
Patient was taking Tracleer (View Usage). Patient had the following side effects: dyspnoea, impaired healing, leg amputation, off label use, peripheral vascular disorder, skin graft, skin ulcer, toe amputation on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Unk Oral. Patient was hospitalized.

6985216-2 | Hepatitis
Adverse event was reported on Sep 03, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: 62.5 Mg, Bid, Oral; 125 Mg, Bid, Oral) was diagnosed with pulmonary arterial hypertension and. Location: FRANCE , 44 years of age, After Tracleer was administered, patient had the following side effects: hepatitis (What is hepatitis?). During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ). Patient was hospitalized.

6985214-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Chills, Gamma-glutamyltransferase Increased, Liver Function Test Abnormal, Platelet Count Decreased, Sluggishness
on Sep 06, 2010 Female patient from JAPAN , 66 years of age, weighting 138.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, gamma-glutamyltransferase increased, liver function test abnormal, platelet count decreased, sluggishness. Tracleer dosage: 62.5 Mg, Bid, Oral; 62.5 Mg, Qd, Oral. During the same period patient was treated with WARFARIN POTASSIUM (WARFARIN POTASSIUM) (View Warfarin Potassium (warfarin Potassium) Review and Warfarin Potassium (warfarin Potassium) Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ). Patient was hospitalized.

6984923-5 | Bronchitis, Urinary Tract Infection
on Sep 08, 2010 Female patient from UNITED STATES , 79 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), urinary tract infection (What is urinary tract infection?). Tracleer dosage: Oral. Patient was hospitalized.

6984921-1 | Atrial Fibrillation, Chills, Oxygen Saturation Decreased, Pyrexia
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chills, oxygen saturation decreased, pyrexia on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ). Patient was hospitalized.

6984918-1 | Myocardial Infarction
Adverse event was reported on Sep 08, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), REVATIO (View Revatio Review and Revatio Label ).

6984913-2 | Cellulitis
on Sep 07, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?). Tracleer dosage: Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6984911-9 | Anaemia, Back Pain, Blood Glucose Increased, Chest Discomfort, Chest Pain, Contusion, Feeling Abnormal, Fluid Retention, Hot Flush
on Sep 03, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: anaemia, back pain (What is back pain?), blood glucose increased, chest discomfort, chest pain (What is chest pain?), contusion, feeling abnormal, fluid retention, hot flush. Tracleer dosage: 125 Mg, Bid, Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6984450-5 | Liver Function Test Abnormal
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6984410-4 | Cardiac Failure Congestive, Dizziness, Pulmonary Oedema
Adverse event was reported on Aug 27, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: cardiac failure congestive, dizziness (What is dizziness?), pulmonary oedema. Patient was hospitalized.

6983331-0 | Chest Pain, Joint Swelling, Oedema Peripheral, Pericardial Effusion, Pleural Effusion, Respiratory Failure
on Sep 01, 2010 Male patient from UNITED STATES , 72 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: chest pain (What is chest pain?), joint swelling, oedema peripheral, pericardial effusion, pleural effusion, respiratory failure. Tracleer dosage: 125 Mg, Bid, Oral, 62.5 Mg, Bid, Oral. Patient was hospitalized.

6983327-9 | Abdominal Distension, Ascites, Gastric Disorder, Hepatic Cirrhosis, Nausea, Urinary Tract Infection, Weight Increased
on Sep 02, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ascites, gastric disorder, hepatic cirrhosis, nausea (What is nausea?), urinary tract infection (What is urinary tract infection?), weight increased. Tracleer dosage: 125 Mg, Bid, Oral.

6983319-X | Condition Aggravated, Diarrhoea, Fluid Retention, Insomnia, Pruritus, Pulmonary Oedema
Patient was taking Tracleer (View Usage). Patient had the following side effects: condition aggravated, diarrhoea, fluid retention, insomnia, pruritus, pulmonary oedema on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. Patient was hospitalized.

6983318-8 | Anaemia, Asthenia, Haemorrhage, Increased Upper Airway Secretion
Adverse event was reported on Aug 31, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 67 years of age, After Tracleer was administered, patient had the following side effects: anaemia, asthenia, haemorrhage, increased upper airway secretion. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6983317-6 | Ileus
on Sep 03, 2010 Female patient from UNITED STATES , 77 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: ileus. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6983316-4 | Asthenia, Cerebrovascular Accident
on Sep 03, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: asthenia, cerebrovascular accident. Tracleer dosage: 125 Mg, Bid, Oral, 62.5 Mg, Bid Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

6983315-2 | Abortion Induced, Pregnancy
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?) on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 125 Mg, Bid, Oral.

6983314-0 | Anaemia, Off Label Use, Urinary Tract Infection, Vertigo
Adverse event was reported on Sep 02, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 81 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, off label use, urinary tract infection (What is urinary tract infection?), vertigo. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

6981553-6 | No Adverse Event
on Sep 02, 2010 Female patient from JAPAN , 39 years of age, weighting 101.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: no adverse event. Tracleer dosage: 125 Mg, Bid, Oral. During the same period patient was treated with EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), FUROSEMIDE (FUROSEMIDE SODIUM) (View Furosemide (furosemide Sodium) Review and Furosemide (furosemide Sodium) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), SORAFENIB TOSILATE (SORAFENIB TOSILATE) (View Sorafenib Tosilate (sorafenib Tosilate) Review and Sorafenib Tosilate (sorafenib Tosilate) Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ).

6981552-4 | Bronchial Disorder, Bronchitis, Cardio-respiratory Arrest, Chronic Respiratory Failure, Condition Aggravated, Hepatitis, Off Label Use, Pharyngeal Disorder, Pulmonary Hypertension
on Aug 30, 2010 Male patient from JAPAN , 73 years of age, weighting 114.6 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: bronchial disorder, bronchitis (What is bronchitis?), cardio-respiratory arrest, chronic respiratory failure, condition aggravated, hepatitis (What is hepatitis?), off label use, pharyngeal disorder, pulmonary hypertension (What is pulmonary hypertension?). Tracleer dosage: 125 Mg, Bid, Oral; 62.5 Mg, Bid, Oral. During the same period patient was treated with TIOTROPIUM BROMIDE (TIOTROPIUM BROMIDE) (View Tiotropium Bromide (tiotropium Bromide) Review and Tiotropium Bromide (tiotropium Bromide) Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), REBAMIPIDE (REBAMIPIDE) (View Rebamipide (rebamipide) Review and Rebamipide (rebamipide) Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ).

6981550-0 | Sepsis
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?) on Sep 02, 2010 from ISRAEL Additional patient health information: Male patient , 80 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral.

6981549-4 |
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: ) . Location: GERMANY , 59 years of age, .

6981542-1 | Myocardial Infarction
on Sep 03, 2010 Male patient from AUSTRIA , 77 years of age, was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: myocardial infarction. Tracleer dosage: Oral.

6981313-6 | Activities Of Daily Living Impaired, Dyscalculia, Memory Impairment, Mental Impairment, Neurological Symptom
on Sep 01, 2010 Female patient from UNITED STATES , 36 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, dyscalculia, memory impairment, mental impairment, neurological symptom. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6981312-4 | Pulmonary Thrombosis
Patient was taking Tracleer (View Usage). Patient had the following side effects: pulmonary thrombosis on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , 44 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6981311-2 | Anaemia, Fall, Head Injury, Oedema, Pneumonia
Adverse event was reported on Aug 31, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 49 years of age, After Tracleer was administered, patient had the following side effects: anaemia, fall (What is fall?), head injury, oedema, pneumonia (What is pneumonia?). During the same period patient was treated with TADALAFIL (TADALAFIL) (View Tadalafil (tadalafil) Review and Tadalafil (tadalafil) Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

6981310-0 |
on Aug 30, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). . Tracleer dosage: Oral.

6981303-3 | Cough, Dyspnoea
on Aug 30, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: cough, dyspnoea. Tracleer dosage: Oral. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

6981302-1 | Device Related Infection, Off Label Use, Pneumonia Staphylococcal
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: device related infection, off label use, pneumonia staphylococcal on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6981301-X | Aneurysm, Arterial Thrombosis Limb, Oedema Peripheral
Adverse event was reported on Aug 31, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: aneurysm (What is aneurysm?), arterial thrombosis limb, oedema peripheral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6981300-8 | Haematological Malignancy, Myeloproliferative Disorder
on Aug 31, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: haematological malignancy, myeloproliferative disorder. Tracleer dosage: Oral.

6981290-8 | Anaemia, Dehydration, Fluid Overload, Humerus Fracture, Hypoxia, Pleural Effusion, Pulmonary Oedema, Syncope
on Aug 26, 2010 Female patient from UNITED STATES , 85 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: anaemia, dehydration, fluid overload, humerus fracture, hypoxia, pleural effusion, pulmonary oedema, syncope. Tracleer dosage: , Oral. During the same period patient was treated with TADALAFIL (TADALAFIL) (View Tadalafil (tadalafil) Review and Tadalafil (tadalafil) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6981289-1 | Diabetes Mellitus, Pulmonary Arterial Hypertension
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, pulmonary arterial hypertension on Aug 27, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: , Oral. Patient was hospitalized.

6981287-8 | Convulsion
Adverse event was reported on Sep 01, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: , Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: convulsion. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

6981286-6 | Infection
on Sep 01, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: infection (What is infection?). Tracleer dosage: , Oral. Patient was hospitalized.

6981278-7 | Arthralgia, Blood Magnesium Decreased, Blood Potassium Decreased, Cystitis, Decreased Appetite, Fatigue, Headache, Hepatitis, Nausea
on Aug 25, 2010 Female patient from UNITED STATES , 51 years of age, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, blood magnesium decreased, blood potassium decreased, cystitis, decreased appetite, fatigue, headache (What is headache?), hepatitis (What is hepatitis?), nausea (What is nausea?). Tracleer dosage: 62.5 Mg, Bid, Oral, 125 Mg, Bid, Oral, 62.5 Mg, Bid, 62.5 Mg, Qd, Oral. During the same period patient was treated with DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ). Patient was hospitalized.

6981276-3 | Arterial Haemorrhage, Haematoma, Nerve Injury, Pain In Extremity
Patient was taking Tracleer (View Usage). Patient had the following side effects: arterial haemorrhage, haematoma, nerve injury, pain in extremity on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: , Oral. Patient was hospitalized.